The Sanford Guide to Antimicrobial Therapy 2012
- List Price:
- Buy New: $12.34
as of 9/21/2014 00:26 EDT details
- You Save: $7.65 (38%)
- Sales Rank:156,267
- Languages:English (Unknown), English (Original Language), English (Published)
- Number Of Items:1
- Edition:42 Updated
- Shipping Weight (lbs):0.2
- Dimensions (in):6.3 x 4.3 x 0.4
- Publication Date:April 1, 2012
Availability:Usually ships in 1-2 business days
- Used Book in Good Condition
Resistance to antibacterial agents is increasing at an alarming pace. Materials on management of resistant gram-positive organisms. Expanded discussion and dosing regimens for Polymyxin B and Polymyxin E (Colistin) are included. There is increasing clinical application of continuous, or prolonged, infusion of antibacterials for those drugs where optimal efficacy correlates with time above MIC of the target bacteria. Antiretroviral therapy options continue to expand with the approval of new drugs, such as rilpivirine, and new combination formulations of ARV drugs such as Complera. A newly approved macrolide, fidaxomicin, is included for treatment of moderate to severe C. difficille toxin-mediated diarrhea.
CERTAIN CONTENT THAT APPEARS ON THIS SITE COMES FROM AMAZON SERVICES LLC. THIS CONTENT IS PROVIDED ‘AS IS’ AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME.